ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 191 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $305,793 | +0.9% | 622 | -50.2% | 0.01% | +100.0% |
Q2 2023 | $303,069 | +403.0% | 1,250 | +97.5% | 0.01% | +133.3% |
Q1 2023 | $60,250 | +66844.4% | 633 | -10.8% | 0.00% | +50.0% |
Q4 2022 | $90 | -99.9% | 710 | +0.6% | 0.00% | 0.0% |
Q3 2022 | $90,000 | +30.4% | 706 | +7.6% | 0.00% | 0.0% |
Q2 2022 | $69,000 | -37.8% | 656 | -37.8% | 0.00% | +100.0% |
Q1 2022 | $111,000 | -20.7% | 1,054 | +168.9% | 0.00% | -66.7% |
Q4 2021 | $140,000 | +14.8% | 392 | -0.5% | 0.00% | +50.0% |
Q3 2021 | $122,000 | -2.4% | 394 | -2.5% | 0.00% | -33.3% |
Q2 2021 | $125,000 | +11.6% | 404 | 0.0% | 0.00% | +50.0% |
Q1 2021 | $112,000 | +8.7% | 404 | +15.1% | 0.00% | -50.0% |
Q4 2020 | $103,000 | +9.6% | 351 | +1.4% | 0.00% | -33.3% |
Q3 2020 | $94,000 | +28.8% | 346 | +3.6% | 0.01% | 0.0% |
Q2 2020 | $73,000 | +58.7% | 334 | -0.9% | 0.01% | +20.0% |
Q1 2020 | $46,000 | -9.8% | 337 | +8.4% | 0.01% | +25.0% |
Q4 2019 | $51,000 | – | 311 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |